Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States

Emily W. Gower, Joshua D. Stein, Nakul S. Shekhawat, Shravani Mikkilineni, Taylor S. Blachley, Nicholas M. Pajewski

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States'. Together they form a unique fingerprint.

Medicine & Life Sciences